1. Selseleh M, Keshavarz H, Mohebali M, Shojaee S, Modarressi MH, Eshragian MR, et al. Production and evaluation of Toxoplasma gondii recombinant surface antigen 1 (SAG1) for serodiagnosis of acute and chronic Toxoplasma infection in human sera. Iran J Parasitol. 2012;7(3):1-9. [
Link]
2. Lim H, Lee SE, Jung BK, Kim MK, Lee MY, Nam HW, et al. Serologic survey of toxoplasmosis in Seoul and Jeju-do, and a brief review of its seroprevalence in Korea. Korean J Parasitol. 2012;50(4):287-93. [
Link] [
DOI:10.3347/kjp.2012.50.4.287]
3. Lee SE, Hong SH, Lee SH, Jeong YII, Lim SJ, Kwon OW, et al. Detection of ocular Toxoplasma gondii infection in chronic irregular recurrent uveitis by PCR. Korean J Parasitol. 2012;50(3):229-31. [
Link] [
DOI:10.3347/kjp.2012.50.3.229]
4. El Behairy AM, Choudhary S, Ferreira LR, Kwok OC, Hilali M, Su C, et al. Genetic characterization of viable Toxoplasma gondii isolates from stray dogs from Giza, Egypt. Vet Parasitol. 2013;193(1-3):25-9. [
Link] [
DOI:10.1016/j.vetpar.2012.12.007]
5. Edwards JF, Dubey JP. Toxoplasma gondii abortion storm in sheep on a Texas farm and isolation of mouse virulent atypical genotype T. gondii from an aborted lamb from a chronically infected ewe. Vet Parasitol. 2013;192(1-3):129-36. [
Link] [
DOI:10.1016/j.vetpar.2012.09.037]
6. Dubey JP, Choudhary S, Kwok OC, Ferreira LR, Oliveira S, Verma SK, et al. Isolation and genetic characterization of Toxoplasma gondii from mute swan (Cygnus olor) from the USA. Vet Parasitol. 2013;195(1-2):42-6.
https://doi.org/10.1016/j.vetpar.2012.12.051 [
Link] [
DOI:10.1016/j.vetpar.2006.04.037]
7. Herrmann DC, Wibbelt G, Götz M, Conraths FJ, Schares G. Genetic characterisation of Toxoplasma gondii isolates from European beavers (Castor fiber) and European wildcats (Felis silvestris silvestris). Vet Parasitol. 2013;191(1-2):108-11. [
Link] [
DOI:10.1016/j.vetpar.2012.08.026]
8. Lilly EL, Wortham CD. High prevalence of Toxoplasma gondii oocyst shedding in stray and pet cats (Felis catus) in Virginia, United States. Parasit Vectors. 2013;6:266. [
Link] [
DOI:10.1186/1756-3305-6-266]
9. Zhang XX, Lou ZZ, Huang SY, Zhou DH, Jia WZ, Su C, et al. Genetic characterization of Toxoplasma gondii from Qinghai vole, Plateau pika and Tibetan ground-tit on the Qinghai-Tibet Plateau, China. Parasit Vectors. 2013;6:291. [
Link] [
DOI:10.1186/1756-3305-6-291]
10. Cabral AD, Gama AR, Sodré MM, Savani ES, Galvão-Dias MA, Jordão LR, et al. First isolation and genotyping of Toxoplasma gondii from bats (Mammalia: Chiroptera). Vet Parasitol. 2013;193(1-3):100-4 [
Link] [
DOI:10.1016/j.vetpar.2012.11.015]
11. Mancianti F, Nardoni S, D'Ascenzi C, Pedonese F, Mugnaini L, Franco F, et al. Seroprevalence, detection of DNA in blood and milk, and genotyping of Toxoplasma gondii in a goat population in Italy. Biomed Res Int. 2013;2013:905326. [
Link]
12. Ortega-Pacheco A, Acosta Viana KY, Guzmán-Marín E, Segura-Correa JC, Alvarez-Fleites M, Jiménez-Coello M. Prevalence and risk factors of Toxoplasma gondii in fattening pigs farm from Yucatan, Mexico. Biomed Res Int. 2013;2013:231497. [
Link]
13. Galván-Ramírez Mde L, Sánchez-Orozco LV, Rodríguez LR, Rodríguez S, Roig-Melo E, Troyo Sanromán R, et al. Seroepidemiology of Toxoplasma gondii infection in drivers involved in road traffic accidents in the metropolitan area of Guadalajara, Jalisco, Mexico. Parasit Vectors. 2013;6(1):294. [
Link] [
DOI:10.1186/1756-3305-6-294]
14. Xu S, Zhang C, He L, Wang T, Ni L, Sun M, et al. DNA detection of Toxoplasma gondii with a magnetic molecular beacon probe via CdTe@Ni quantum dots as energy donor. J Nanomater. 2013;2013:473703. [
Link]
15. Cong W, Huang SY, Zhou DH, Zhang XX, Zhang NZ, Zhao Q, et al. Prevalence and genetic characterization of Toxoplasma gondii in house sparrows (Passer domesticus) in Lanzhou, China. Korean J Parasitol. 2013;51(3):363-7. [
Link] [
DOI:10.3347/kjp.2013.51.3.363]
16. Khademvatan S, Saki J, Yousefi E, Abdizadeh R. Detection and genotyping of Toxoplasma gondii strains isolated from birds in the Southwest of Iran. Br Poult Sci. 2013;54(1):76-80. [
Link] [
DOI:10.1080/00071668.2013.763899]
17. Jenks SJ, Conway BR, Mc Lachlan S, Teoh WL, Williamson RM, Webb DJ, et al. Cardiovascular disease biomarkers are associated with declining renal function in type 2 diabetes. Diabetologia. 2017;60(8):1400-8. [
Link] [
DOI:10.1007/s00125-017-4297-0]
18. Chokengarmwong N, Yeh DD, Chang Y, Ortiz LA, Kaafarani HMA, Fagenholz P, et al. Elevated admission N-terminal pro-brain natriuretic peptide level predicts the development of atrial fibrillation in general surgical intensive care unit patients. J Trauma Acute Care Surg. 2017;83(3):485-90. [
Link] [
DOI:10.1097/TA.0000000000001552]
19. Taylor CJ, Monahan M, Roalfe AK, Barton P, Iles R, Hobbs FDR. The REFER (REFer for EchocaRdiogram) study: A prospective validation and health economic analysis of a clinical decision rule, NT-proBNP or their combination in the diagnosis of heart failure in primary care. Effic Mech Eval. 2017 Apr. 28- Uçkay I, Garzoni C, Ferry T, Harbarth S, Stern R, Assal M, et al. Postoperative serum pro-calcitonin and C-reactive protein levels in patients with orthopedic infections. Swiss Med Wkly. 2010;140:w13124. [
Link]
20. Lewis LK, Raudsepp SD, Yandle TG, Prickett TC, Richards AM. Development of a BNP1-32 immunoassay that does not cross-react with proBNP. Clin Chem. 2017;63(6):1110-7. [
Link] [
DOI:10.1373/clinchem.2016.269712]
21. Tu WJ, Ma GZ, Ni Y, Hu XS, Luo DZ, Zeng XW, et al. Copeptin and NT-proBNP for prediction of all-cause and cardiovascular death in ischemic stroke. Neurology. 2017;88(20):1899-905. [
Link] [
DOI:10.1212/WNL.0000000000003937]
22. Popelová JR, Tomková M, Tomek J. NT-proBNP predicts mortality in adults with transposition of the great arteries late after Mustard or Senning correction. Congenit Heart Dis. 2017;12(4):448-57. [
Link] [
DOI:10.1111/chd.12466]
23. Jia J, Chang GL, Qin S, Chen J, He WY, Lu K, et al. Comparative evaluation of copeptin and NT-proBNP in patients with severe acute decompensated heart failure, and prediction of adverse events in a 90-day follow-up period: A prospective clinical observation trial. Exp Ther Med. 2017;13(4):1554-60. [
Link] [
DOI:10.3892/etm.2017.4111]
24. Potter JM, Simpson AJ, Kerrigan J, Southcott E, Salib MM, Koerbin G, et al. The relationship of plasma creatinine (as eGFR) and high-sensitivity cardiac troponin and NT-proBNP concentrations in a hospital and community outpatient population. Clin Biochem. 2017;50(15):813-5. [
Link] [
DOI:10.1016/j.clinbiochem.2017.04.003]
25. Hwang JW, Park SJ, Cho EJ, Kim EK, Lee GY, Chang SA, et al. Relation of N-Terminal Pro-B-Type natriuretic peptide and left ventricular diastolic function to exercise tolerance in patients with significant valvular heart disease and normal left ventricular systolic function. Am J Cardiol. 2017;119(11):1846-53. [
Link] [
DOI:10.1016/j.amjcard.2017.02.038]
26. Bijsmans ES, Jepson RE, Wheeler C, Syme HM, Elliott J. Plasma N-Terminal probrain natriuretic peptide, vascular endothelial growth factor, and cardiac troponin i as novel biomarkers of hypertensive disease and target organ damage in cats. J Vet Intern Med. 2017;31(3):650-60. [
Link] [
DOI:10.1111/jvim.14655]
27. Akcay I, Okoh AK, Yalav O, Eray IC, Rencuzogullari A, Dalci K, et al. The prognostic value of pro-calcitonin, CRP and thyroid hormones in secondary peritonitis: a single-center prospective study. Ulus Travma Acil Cerrahi Derg. 2014;20(5):343-52. [
Link] [
DOI:10.5505/tjtes.2014.98354]
28. Uçkay I, Garzoni C, Ferry T, Harbarth S, Stern R, Assal M, et al. Postoperative serum pro-calcitonin and C-reactive protein levels in patients with orthopedic infections. Swiss Med Wkly. 2010;140:w13124. [
Link] [
DOI:10.4414/smw.2010.13124]
29. Mol JA, Kwant MM, Arnold IC, Hazewinkel HA. Elucidation of the sequence of canine (pro)-calcitonin, a molecular biological and protein chemical approach. Regul Pept. 1991;35(3):189-95. [
Link] [
DOI:10.1016/0167-0115(91)90082-R]